FDA Inspection 1117961 — Lilly France S.A.S.
The FDA completed an inspection of Lilly France S.A.S. on Jan 16, 2020 in Fegersheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Fegersheim (France)